[
  {
    "ts": null,
    "headline": "Guggenheim Remains Bullish on Pfizer (PFE)",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best drug stocks to buy right now. In a report released on September 5, Vamil Divan from Guggenheim maintained a Buy rating on Pfizer Inc. (NYSE:PFE), setting a price target of $33.00. In other news, Pfizer Inc. (NYSE:PFE) and BioNTech SE announced on September 8 positive topline results from an […]",
    "url": "https://finnhub.io/api/news?id=268dc13fcae094b74f50c422e8d51fe96e031bd41acb92008670de096cdb6b74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758052693,
      "headline": "Guggenheim Remains Bullish on Pfizer (PFE)",
      "id": 136782186,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is one of the best drug stocks to buy right now. In a report released on September 5, Vamil Divan from Guggenheim maintained a Buy rating on Pfizer Inc. (NYSE:PFE), setting a price target of $33.00. In other news, Pfizer Inc. (NYSE:PFE) and BioNTech SE announced on September 8 positive topline results from an […]",
      "url": "https://finnhub.io/api/news?id=268dc13fcae094b74f50c422e8d51fe96e031bd41acb92008670de096cdb6b74"
    }
  },
  {
    "ts": null,
    "headline": "39 Reader Faves Tap 9 Ideal \"Safer\" Dividends In August",
    "summary": "This article emphasizes a contrarian, yield-based strategy, encouraging readers to 'Be More Dog' and use these stocks as research starting points, not recommendations. Read it here.",
    "url": "https://finnhub.io/api/news?id=94f226f06d0d52b281d5db53ef004e8ba186ffc4e1d6424ce0a0f126c8c0b2e9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758042026,
      "headline": "39 Reader Faves Tap 9 Ideal \"Safer\" Dividends In August",
      "id": 136782956,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/931250842/image_931250842.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "This article emphasizes a contrarian, yield-based strategy, encouraging readers to 'Be More Dog' and use these stocks as research starting points, not recommendations. Read it here.",
      "url": "https://finnhub.io/api/news?id=94f226f06d0d52b281d5db53ef004e8ba186ffc4e1d6424ce0a0f126c8c0b2e9"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna (MRNA) Stock Is Trading Up Today",
    "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®.",
    "url": "https://finnhub.io/api/news?id=cf96ef5e36f7ef4c079727eb1718b3f7aff25f243313608439755963d70b0008",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758040849,
      "headline": "Why Moderna (MRNA) Stock Is Trading Up Today",
      "id": 136773040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®.",
      "url": "https://finnhub.io/api/news?id=cf96ef5e36f7ef4c079727eb1718b3f7aff25f243313608439755963d70b0008"
    }
  },
  {
    "ts": null,
    "headline": "MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer",
    "summary": "Merck and Daiichi's raludotatug deruxtecan wins FDA Breakthrough tag for treating CDH6 expressing platinum-resistant ovarian, primary peritoneal or fallopian tube cancers.",
    "url": "https://finnhub.io/api/news?id=2295b25cd6213388d0d465383b3c8286fd0818cfff2954fca665ad0c1dc085fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758039540,
      "headline": "MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer",
      "id": 136781314,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Merck and Daiichi's raludotatug deruxtecan wins FDA Breakthrough tag for treating CDH6 expressing platinum-resistant ovarian, primary peritoneal or fallopian tube cancers.",
      "url": "https://finnhub.io/api/news?id=2295b25cd6213388d0d465383b3c8286fd0818cfff2954fca665ad0c1dc085fd"
    }
  },
  {
    "ts": null,
    "headline": "Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?",
    "summary": "GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.",
    "url": "https://finnhub.io/api/news?id=a72bd43a5ff64703e4335b99fdc014a2ce698e0b3a592d227a958b35d126c478",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758039300,
      "headline": "Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?",
      "id": 136775115,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.",
      "url": "https://finnhub.io/api/news?id=a72bd43a5ff64703e4335b99fdc014a2ce698e0b3a592d227a958b35d126c478"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light",
    "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), a global healthcare company formed from the 2020 merger of Mylan and Pfizer’s Upjohn division, continues to expand its presence in both generics and specialty pharmaceuticals. Operating in […]",
    "url": "https://finnhub.io/api/news?id=af7fa859e06e14f8e294f507ea478ac2c0934674bef428cbc6a77d181bc5a826",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758033089,
      "headline": "Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light",
      "id": 136773513,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), a global healthcare company formed from the 2020 merger of Mylan and Pfizer’s Upjohn division, continues to expand its presence in both generics and specialty pharmaceuticals. Operating in […]",
      "url": "https://finnhub.io/api/news?id=af7fa859e06e14f8e294f507ea478ac2c0934674bef428cbc6a77d181bc5a826"
    }
  },
  {
    "ts": null,
    "headline": "Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine",
    "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance innovative medicines and vaccines across oncology, immunology, rare diseases, and more. The company gained worldwide recognition for its COVID-19 vaccine developed with […]",
    "url": "https://finnhub.io/api/news?id=495f6ffc1871afa3c2acc84a21d796544f8c2b4aee8af8f2bf0b4601edaa15bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758032779,
      "headline": "Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine",
      "id": 136773514,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance innovative medicines and vaccines across oncology, immunology, rare diseases, and more. The company gained worldwide recognition for its COVID-19 vaccine developed with […]",
      "url": "https://finnhub.io/api/news?id=495f6ffc1871afa3c2acc84a21d796544f8c2b4aee8af8f2bf0b4601edaa15bd"
    }
  },
  {
    "ts": null,
    "headline": "3 Things You Need to Know If You Buy Pfizer Today",
    "summary": "Pfizer has an attractive 7.2% dividend yield, but this healthcare giant might be a riskier dividend stock than you want to own.",
    "url": "https://finnhub.io/api/news?id=d570977e39a880efa07fe7465131a6aa2c2594fe11e9542ea314b7a1d0d594e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758015600,
      "headline": "3 Things You Need to Know If You Buy Pfizer Today",
      "id": 136773515,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer has an attractive 7.2% dividend yield, but this healthcare giant might be a riskier dividend stock than you want to own.",
      "url": "https://finnhub.io/api/news?id=d570977e39a880efa07fe7465131a6aa2c2594fe11e9542ea314b7a1d0d594e0"
    }
  },
  {
    "ts": null,
    "headline": "3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever",
    "summary": "A good stock is an even better buy when it's on sale, even if your primary goal is immediate and reliable income.",
    "url": "https://finnhub.io/api/news?id=20a504dcc61ad2cb13076808338e88edc93b34e9320255f99e8e49a21fcd9669",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758014520,
      "headline": "3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever",
      "id": 136773494,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A good stock is an even better buy when it's on sale, even if your primary goal is immediate and reliable income.",
      "url": "https://finnhub.io/api/news?id=20a504dcc61ad2cb13076808338e88edc93b34e9320255f99e8e49a21fcd9669"
    }
  }
]